Albuquerque Clinical Trials, Inc.
Albuquerque, New Mexico, United States
Research institute in Albuquerque, New Mexico
711 Encino Pl NE, Albuquerque, NM 87102
About Albuquerque Clinical Trials, Inc.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Albuquerque Clinical Trials, Inc.
During the past decade, Albuquerque Clinical Trials, Inc. conducted 66 clinical trials. In the 10-year time frame, 66 clinical trials started and 63 clinical trials were completed, i.e. on
average, 95.5% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 35 clinical trials were completed. i.e. 166.7%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
1999-04-01
2016-05-01
Completed
854
Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
1999-05-01
2012-08-01
Completed
19,747
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
2000-10-01
2019-11-01
Completed
1,772
Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
2002-05-01
2014-06-01
Completed
3,871
EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast Cancer
2002-12-01
2015-04-01
Completed
226
Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
2002-12-01
2016-12-01
Completed
546
Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
2003-01-01
2016-05-01
Completed
3,104
Polyglutamate Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
2003-01-01
2004-10-01
Terminated
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Albuquerque Clinical Trials, Inc." #1 sponsor was "Pfizer" with 19 trials, followed by "Eli Lilly and Company" with 14 trials
sponsored, "Allergan" with 5 trials sponsored, "Bristol-Myers Squibb" with 5 trials sponsored and "Gilead Sciences"
with 5 trials sponsored. Other sponsors include 49 different institutions and
companies that sponsored additional 47 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Albuquerque Clinical Trials, Inc."
#1 collaborator was "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "PPD" with 2 trials as a collaborator, "Alder Biopharmaceuticals, Inc." with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were
collaborators in the rest 18 trials.
Clinical Trials Conditions at Albuquerque Clinical Trials, Inc.
According to Clinical.Site data, the most researched conditions in "Albuquerque Clinical Trials, Inc." are
"Migraine" (18 trials), "Rheumatoid Arthritis" (11 trials), "Arthritis" (5 trials), "Low Back Pain" (5 trials) and "Osteoarthritis" (5 trials). Many other conditions were trialed in "Albuquerque Clinical Trials, Inc." in a lesser frequency.
Clinical Trials Intervention Types at Albuquerque Clinical Trials, Inc.
Most popular intervention types in "Albuquerque Clinical Trials, Inc." are "Drug" (91 trials), "Biological" (14 trials), "Other" (12 trials), "Behavioral" (3 trials) and "Dietary Supplement" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (52 trials), "Galcanezumab" (6 trials), "Baricitinib" (4 trials), "placebo" (4 trials) and "Atogepant" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Albuquerque Clinical Trials, Inc.
The vast majority of trials in "Albuquerque Clinical Trials, Inc." are
93 trials for "All" genders and 9 trials for "Female" genders.
Clinical Trials Status at Albuquerque Clinical Trials, Inc.
Currently, there are NaN active trials in "Albuquerque Clinical Trials, Inc.".
undefined are not yet recruiting,
8 are recruiting,
5 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 78 completed trials in Albuquerque Clinical Trials, Inc.,
1 suspended trials,
and 7 terminated clinical trials to date.
Out of the total trials that were conducted in Albuquerque Clinical Trials, Inc., 1 "Phase 1"
clinical trials were conducted, 35 "Phase 2" clinical
trials and 65 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 5 trials, and there were
also 0 trials that are defined as “Not Applicable".